Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNSON & JOHNSON VISION CARE, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: 1K

Market Cap: -

Website: http://www.jnjvision.com

Clinical Trials

Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: galyfilcon A
Device: galyfilcon A plus
Device: lotrafilcon A
Device: polymacon
Other: spectacles

First Posted Date: 2011-12-01

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 21

Registration Number: NCT01482819

Daily Disposable Performance of 1•DAY ACUVUE® TruEye™ and 1•DAY ACUVUE® MOIST® With LACREON® TECHNOLOGY

Completed

Conditions: Hyperopia
Myopia

Interventions: Device: etafilcon A daily disposable soft contact lenses
Device: narafilcon B daily disposable soft contact lenses

First Posted Date: 2011-11-08

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 1171

Registration Number: NCT01467557

Prospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses

Not Applicable

Completed

Conditions: Refractive Errors

Interventions: Device: narafilcon A contact lens
Device: nelfilcon A soft contact lenses

First Posted Date: 2011-09-30

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 40

Registration Number: NCT01444313

Daytime Corneal Swelling During Wear of Narafilcon B Lenses

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Polymacon
Device: Lotrafilcon A
Other: Spectacles
Device: narafilcon B

First Posted Date: 2011-09-30

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 22

Registration Number: NCT01444287

Locations: 🇦🇺
Coles-Brennan Pty Ltd, Hawthorn, Victoria, Australia

Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses

Completed

Conditions: Refractive Errors

Interventions: Device: No Intervention

First Posted Date: 2011-09-30

Last Posted Date: 2017-06-20

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 41

Registration Number: NCT01444053

Mucin Balls and Corneal Inflammation Events

Phase 1

Completed

Conditions: Corneal Infiltrative Events
Corneal Inflammation

Interventions: Device: lotrafilcon A
Device: comfilcon A
Device: balafilcon A
Other: etafilcon A

First Posted Date: 2011-09-20

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 289

Registration Number: NCT01437319

Comparison of Lens Fit and Lens Power of a New Contact Lens to Two Marketed Contact Lenses in a Population of Soft Contact Lens Wearers

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: galy A Plus
Device: seno A
Device: galy A

First Posted Date: 2010-11-19

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 41

Registration Number: NCT01244529

Study of ACUVUE® ADVANCE® PLUS Contact Lenses.

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Acuvue Advance Plus prePQ
Device: Acuvue Advance Plus postPQ

First Posted Date: 2010-11-19

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 44

Registration Number: NCT01244893

Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: lotrafilcon B, BC 8.60
Device: comfilcon A, BC 8.60
Device: galyfilcon A, BC 8.30

First Posted Date: 2010-11-19

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 540

Registration Number: NCT01244516

Pilot Dispensing Evaluation of a Plus Power Lens

Not Applicable

Completed

Conditions: Hyperopia

Interventions: Device: Acuvue Advance Plus
Device: Acuvue Advance

First Posted Date: 2010-10-26

Last Posted Date: 2018-06-19

Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Target Recruit Count: 38

Registration Number: NCT01228591

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy